4/A
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046266
Options or other derivatives
- Chief Scientific Officer acquired 15,177 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-05-23 | Option exercise · Stock option (right to buy) | −15,177 | 14,862 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…